Ameren’s recent catalysts
Ameren (AEE) has been in focus after a J.P. Morgan rating upgrade linked to expected AI data center demand, alongside Ameren Transmission Company of Illinois winning MISO backed high voltage transmission projects in Illinois.
See our latest analysis for Ameren.
Ameren’s recent rating upgrade and transmission wins have coincided with a 1-day share price return of 1.32% and a year to date share price return of 10.34%. The 5 year total shareholder return of 52.95% points to momentum being in place rather than just a short term reaction.
If you are looking beyond utilities, this is a good moment to scan other power grid opportunities with the Simply Wall St screener for 35 power grid technology and infrastructure stocks
With Ameren stock up 10.3% year to date and trading at $111.29, yet showing an intrinsic value estimate around 16% above that level, is the recent excitement over AI data centers still mispriced or fully reflected?
Most Popular Narrative: 8% Undervalued
The most followed narrative pegs Ameren’s fair value at about $120, a premium to the last close at $111.29, and builds that view around long run grid demand.
Ongoing and future investments in grid modernization, resilience (e.g., smart substations, composite poles, automation), and clean energy resources (wind, solar, batteries) are expected to expand Ameren's regulated rate base at a forecasted 9.2% CAGR, enabling higher allowed returns and improved net margins.
Want to see the full playbook behind that valuation gap? The narrative leans on grid spending, steady sales growth and a richer future earnings multiple. The exact mix of growth, margins and discounting might surprise you.
Result: Fair Value of $120.40 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that gap only matters if data center demand and grid investment approvals arrive as planned, and if regulatory or tax credit support does not weaken.
Find out about the key risks to this Ameren narrative.
Another View: DCF Says Ameren May Be Overpriced
The narrative around Ameren hinges on an 8% upside to a fair value of about $120, yet the Simply Wall St DCF model points the other way. On that cash flow view, Ameren at $111.29 screens above an estimated value of $96.08, which indicates potential downside risk if cash flows fall short.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ameren for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 48 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Given the mix of optimism and concern throughout this article, this is a good time to look at the evidence yourself and decide where you stand, starting with the 3 key rewards and 3 important warning signs.
Looking for more investment ideas?
If you stop with Ameren, you risk missing other opportunities that fit your style, so put the wider market to work for you with a quick screen.
- Target resilient cash generators by scanning the 48 high quality undervalued stocks that pair quality fundamentals with room for potential upside.
- Lock in potential income streams by checking the 10 dividend fortresses built around dividend yields of 5% or more.
- Dial down portfolio risk by focusing on the 69 resilient stocks with low risk scores designed to spotlight companies with sturdier profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com